An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness

Toxicologic Pathology

Volumn 26, Issue 4, 1998, Pages 548-555

  Thompson, Karol L ^a   Rosenzweig, Barry A ^a   Sistare, Frank D ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

12 O tetradecanoylphorbol 13 acetate; Gene amplification; Genetic instability; Inverted repeat; Palindrome; Southern blot hybridization; Zeta globin

Indexed keywords

PALINDROMIC DNA; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CARCINOGEN TESTING; CONTROLLED STUDY; GENOTYPE; HEMIZYGOSITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0031873002     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339802600411     Document Type: Article

References (11)

1. Akgun E, Zahn J, Baumes S, Brown G, Liang F, Romanienko PJ, Lewis S, and Jasin M (1997). Palindrome resolution and recombination in the mammalian germ line. Mol. Cell Biol. 17: 5559-5570.
2. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, and Struhl K (eds.) (1993). Current Protocols in Molecular Biology, Vol. 1, Suppl. 21. John Wiley & Sons, New York.
3. Blanchard KT, Ball DJ, Holden HE, Furst SM, Stoltz JH, and Stoll RE (1998). Dermal carcinogenicity in transgenic mice: Relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-O-tetradecanoylphorbol 13-acetate (TPA) and benzene. Toxicol. Pathol. 26: 541-547 (this issue).
4. Collick A, Drew J, Penberth J, Bois P, Luckett J, Scaerou F, Jeffreys A, and Reik W (1996). Instability of long inverted repeats within mouse transgenes. EMBO J. 15: 1163-1171.
5. Crouse JF, Davis VL, Tally WC, and Korach KS (1994). An improved method of genomic DNA extraction for screening transgenic mice. BioTechniques 17: 1030-1032.
6. Ford M and Fried M (1986). Large inverted duplications are associated with gene amplification. Cell 45: 425-430.
7. French JE, Libbus BL, Hansen L, Spalding J, Tice RR, Mahler J, and Tennant RW (1994). Cytogenetic analysis of malignant skin tumors induced in chemically treated Tg.AC transgenic mice. Mol. Carcinog. 11: 215-226.
8. Hyrien O, Debatisse M, Buttin G, and de Saint Vincent BR (1988). The multicopy appearance of a large inverted duplication and the sequence at the inversion joint suggest a new model for gene amplification. EMBO J. 7: 407-417.
9. Leder A, Kuo A, Cardiff RD, Sinn E, and Leder P (1990). v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA 87: 9178-9182.
10. Spalding JW, Momma J, Elwell MR, and Tennant RW (1993). Chemically induced skin carcinogensis in a transgenic mouse line (Tg.AC) carrying a v-Ha-ras gene. Carcinogenesis 14: 1335-1341.
11. Weaver JL, Contrera JF, Rosenzweig BA, Thompson KL, Faustino PJ, Strong JM, Ellison CD, Anderson LW, Prasanna HR, Long-Bradley PE, Lin KK, Zhang J, and Sistare FD (1998). An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype. Toxicol. Pathol. 26: 532-540 (this issue).